Immunocore has a sip with USD140m private placement
Immunocore Holdings plc (Nasdaq: IMCR), a biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific...
G7 heads call for decarbonisation of industry
The G7 ministers underlined the importance of efforts to improve energy efficiency, the need for increased investment in renewable energy, tracking...
Lonza invests CHF500m in Large-Scale Facility in Stein (CH)
Since establishing drug product development and manufacturing services in 2016, Lonza has expanded its clinical drug product offering...
Spatial Biology Company Navinci (Olink) closes EUR9m Series A
Navinci advances spatial proteomics by launching high-performance assay kits, based on proprietary in situ Proximity Ligation Assay technology for...
Cannabis players Canify AS and Bavaria Weed merge to form Canify AG
The merger combines Canify AS’s expertise in the production of pharna-grade medical cannabis with the market position of Bavaria Weed GmbH, as...
International Vaccine Institute – IVI – will locate its European office in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified...